UK's FTSE 100 inched up on Friday boosted by AztraZeneca gains after the drugmaker got U.S. regulator's nod for an experimental antibody, while payments provider Network International surged on reaching an agreement to be taken private.
The FTSE 100 benchmark index rose 0.1% as of 0711 GMT, boosted by a 0.8% gain in AstraZeneca after the U.S. Food and Drug Administration advisers backed the use of the drug maker and partner Sanofi's experimental antibody to prevent respiratory infections in infants.
Comments
Post a Comment